Abbott Laboratories (ABT) reports robust earnings growth and margin expansion, driven by medical devices, despite headwinds ...

ABT earnings call for the period ending June 30, 2024. The Motley Fool. Abbott Laboratories (ABT) Q2 2024 Earnings Call Transcript. ... Should you invest $1,000 in Abbott Laboratories right now?

The Motley Fool. DATE Thursday, July 17, 2025 at 9 a.m. ET CALL PARTICIPANTS Chairman and Chief Executive Officer — Robert ...

Abbott Laboratories (NYSE:ABT) Q4 2023 Earnings Conference Call January 24, 2024 9:00 AM ETCompany Participants. Mike Comilla - Vice President, Investor Relations Robert Ford - Chairman and Chief ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

Live Updates Live Coverage Updates appear automatically as they are published. Still no earnings at 7:05 a.m. ET 7:04 am by ...

Barclays analyst Matt Miksic maintained an Overweight rating and increased the price target from $158 to $159 on April 17, ...

ABBOTT PARK, Ill., June 25, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its second-quarter 2021 financial results on Thursday, July 22, 2021, before the market opens. The announcement ...

ABT earnings call for the period ending December 31, 2023. ... Abbott Laboratories (NYSE: ABT) Q4 2023 Earnings Call Jan 24, 2024, 9:00 a.m. ET. Contents: Prepared Remarks. Questions and Answers.

Q2 2025 Results Conference Call July 17, 2025 9:00 AM ETCompany ParticipantsMichael Comilla - Vice President of ...

Abbott Laboratories reports earnings inline with expectations. Reported EPS is $1.19 EPS, expectations were $1.19. ... Welcome to Abbott’s Fourth Quarter 2023 Earnings Conference Call.

Abbott Laboratories beats earnings expectations. Reported EPS is $1.14, expectations were $1.1. Operator: Good morning, and thank you for standing by. Welcome to Abbott’s Third Quarter 2023 ...